Search Results for “aging” – Page 14 – media

New president of Beckman takes office

Recently, according to the official website of Beckman Coulter Life Sciences, Danaher subsidiary Beckman Coulter Life Sciences (hereinafter referred to as Beckman) announced the appointment of Joe Fox as president, effective immediately. It is understood that Joe Fox is a veteran of Danaher. He served as president of Danaher subsidiary Sciex, and before becoming president, he held several leadership positions in the company, including senior vice president of global sales and services. In 13 years, Joe Fox has held positions with increasing responsibilities until he became president recently. Before joining Sciex, Joe Fox held technical and commercial positions at Bruker and Shimadzu, and Joe Fox also holds a degree in biochemistry from the University of Delaware and a doctorate in chemistry from Johns Hopkins University. After taking office, Joe Fox will lead a global team of more than 3,300 employees to promote product and service innovation to provide solutions in ...
- Source: drugdu
- 78
- October 12, 2024
A major pharmaceutical province issued a document to dig deep into medical corruption

In May this year, the National Health Commission and 14 other departments issued the “Notice on Printing and Distributing the Key Points for Correcting Unhealthy Trends in the Field of Pharmaceutical Purchase and Sale and Medical Services in 2024”, which includes 5 parts and 15 items. The local level has also successively issued the key points for correcting unhealthy trends in 2024. Judging from the above-mentioned “Notice” issued by Shanghai, the key points for Shanghai’s corrective work in 2024 are basically consistent with the national documents, and some new content has also been added, totaling 5 parts and 18 items. The “Notice” clearly states that the city’s centralized rectification of corruption in the pharmaceutical field and the centralized rectification of unhealthy trends and corruption around the masses should be carried out in a coordinated manner, and the construction of systems in the field of pharmaceutical purchase and sale should be ...
- Source: drugdu
- 87
- October 12, 2024
Drugdu.com Shines at CPhI Milan 2024

▲October 2024, CPhI Milan On October 10, 2024, the highly anticipated CPhI Milan event concluded in Italy, leaving behind a lasting impression. Drugdu.com, a global leader in cross-border pharmaceutical B2B platforms, stood out with its innovative digital solutions and accurate buyer-supplier matching services, garnering widespread attention from the global pharmaceutical community. ▲Drugdu.com at the CPhI Milan show in October 2024 Platform Highlights: Smart Cross-Border Trade Services At the event, Drugdu.com demonstrated its leading smart supply-demand matching feature, allowing buyers to effortlessly post procurement needs and swiftly connect with high-quality global suppliers. The platform’s real-time, efficient negotiations boosted transaction success, with many participants leveraging its capabilities to finalize collaborations during the exhibition. Additionally, Drugdu.com provided VIP members with customized promotion strategies, offering exclusive brand exposure and diverse inquiry channels to help businesses expand their global market presence. Advancing Digital Pharmaceutical Trade Beyond being a platform, Drugdu.com is committed to advancing the digitalization ...
- Source: drugdu
- 76
- October 11, 2024
Beckman’s new president takes office

Recently, according to the official website of Beckman Coulter Life Sciences, a subsidiary of Danaher, Beckman Coulter Life Sciences announced the appointment of Joe Fox as President, effective immediately. Following the promotion of Chen Xiaoxiao, former General Manager of Beckman Clinical Diagnostics China, to President of Danaher China Medical Diagnostic Platform in the first half of the year, Beckman has once again announced personnel changes. It is understood that Joe Fox is a veteran of Danaher and has served as the president of Danaher’s subsidiary, Sciex. Prior to becoming president, he held multiple leadership positions at the company, including Senior Vice President of Global Sales and Service. Over the course of 13 years, Joe Fox’s responsibilities have increased, until he recently became president. Prior to joining Sciex, Joe Fox held technical and business positions at Bruker and Shimadzu, and also holds a Bachelor of Science degree in Biochemistry from the ...
- Source: drugdu
- 81
- October 11, 2024
ARCH completes $3 billion fundraising! Focus on AI pharmaceuticals

ARCH Venture Partners, an American biotech investment institution, announced the completion of over $3 billion in ARCH Venture Fund XIII fundraising, aimed at supporting the establishment and development of early-stage biotech companies. The 13th fund was established following the 12th fund of $2.975 billion announced in June 2022. “After 38 years, ARCH’s investment philosophy remains the same: we bet on great science and great teams to build breakthrough companies,” said Robert Nelsen, co-founder and managing director of ARCH. “We believe that artificial intelligence and new data-driven insights into biology will help build a more preventive, curative and equitable healthcare system.” “ARCH has a long history of identifying the top forward-looking trends in life science R&D and individuals who drive truly groundbreaking scientific hypotheses,” said Keith Crandell, co-founder and managing director of ARCH. “We are very excited about the pace of innovation and efforts to understand diseases at a deeper level.” ...
- Source: drugdu
- 70
- October 11, 2024
Investing 22.88 million yuan, leading pharmaceutical company has obtained clinical approval for nuclear drugs!

The board of directors and all directors of our company guarantee that there are no false records, misleading statements or significant omissions in the content of this announcement, and assume legal responsibility for the authenticity, accuracy and completeness of its content. Recently, Tianjin Hengrui Pharmaceutical Co., Ltd., a subsidiary of Jiangsu Hengrui Pharmaceutical Co., Ltd. (hereinafter referred to as the “Company”), received approval from the National Medical Products Administration (hereinafter referred to as the “NMPA”) to issue a “Drug Clinical Trial Approval Notice” for fluoride [18F] metoprolol injection, and will conduct clinical trials in the near future. Basic information of drugs Drug Name: Fluorine [18F] Metoprolol Injection Form: Injection Application Matters: Clinical Trial Acceptance Number: CYHL2400142 Approval Conclusion: According to the Drug Administration Law of the People’s Republic of China and relevant regulations, after examination, the Fluorine [18F] Metoprolol Injection accepted on July 9, 2024 meets the relevant requirements for ...
- Source: drugdu
- 87
- October 10, 2024
Vietnam Medipharm Expo

Organiser：Ministry of Health of Vietnam Time：July 31 – August 2, 2025 Address：799 Đ. Nguyễn Văn Linh, Tân Phú, Quận 7, Hồ Chí Minh, Vietnam Exhibition hall：Saigon Exhibition and Convention Center (SECC) Product range: Medical Products: Medical equipment and instruments, medical consumables, medical dressings, surgical equipment, rescue equipment, diagnostic equipment and supplies, ophthalmic instruments and equipment, ENT equipment, dental equipment and supplies, medical reagents and equipment, medical health products and equipment, medical institution and laboratory technology equipment, medical information and technology exchange, beauty instruments Analytical Instruments: Optical analysis instruments, mass spectrometers, spectrographs, chromatographs, spectroscopes, frequency spectrum analyzers, electrochemical analysis instruments, ray analysis instruments, gas chromatography, liquid chromatography, thermal analysis instruments, various portable instruments, surface analysis instruments, nuclear analysis instruments, elemental analysis instruments, process analysis instruments, component analysis instruments, syringe analysis instruments, and other general analytical instruments Laboratory Equipment: Laboratory instruments and equipment, laboratory automation and accessories, optical equipment, microscopes, optical ...
- Source: drugdu
- 96
- October 10, 2024
Pharmintech in Italy

Organiser：Hannover Milano Fairs Time：May 27 – 30, 2025 Address：Strada Statale Sempione, 28, 20017 Rho MI Exhibition hall：Fiera Milano Rho Product range: Pharmaceutical Raw Material Equipment: Reaction equipment, drying equipment, crystallization equipment, centrifuges, extraction equipment, heat exchangers, storage equipment, filtration equipment, evaporation equipment, distillation equipment, screening machinery, sterilization equipment, filter press equipment, homogenizers, etc. Pharmaceutical Dosage Form Equipment: Pill machinery, ointment machinery, eye drop machinery, tablet machinery, tincture, syrup machinery, granule machinery, soft capsule machinery, aqueous injection machinery, hard capsule machinery, suppository machinery, oral liquid machinery, medicinal film machinery, aerosol machinery, antibiotic powder machinery, coating machines, pharmaceutical filling machines, jet mills, pharmaceutical grinders, low-temperature grinders, pharmaceutical grinding units, mechanical pharmaceutical grinders, ultra-fine grinders, granulators, mixing equipment, bottle conveying machines, bottle arranging machines, bottle washing machines, aeration devices, capping machines, feeding devices, etc. Pharmaceutical Packaging Machinery: Weighing equipment, bag packaging machines, pillow packaging machines, blister packaging machines, bottling lines, printing machines, ...
- Source: drugdu
- 100
- October 8, 2024
What does it mean to have a dual system in healthcare?

On September 8, the Ministry of Commerce, the National Health Commission, and the State Food and Drug Administration jointly issued the Notice on Carrying out Pilot Work on Expanding Opening-up in the Medical Field (hereinafter referred to as the “Notice”). It is proposed to allow the establishment of wholly foreign-owned hospitals (except for traditional Chinese medicine, excluding mergers and acquisitions of public hospitals) in Beijing, Tianjin, Shanghai, Nanjing, Suzhou, Fuzhou, Guangzhou, Shenzhen and Hainan. This is undoubtedly a bold innovation to the existing healthcare system. Previously, foreign investment was limited to joint venture hospitals, and there were many restrictions such as shareholding ratio. With the relaxation of policy restrictions and the introduction of foreign-funded medical institutions, as more high-end medical institutions enter the Chinese market, while diverting some high-end patients, it may also improve the development and progress of the overall medical level in China. There are two main points ...
- Source: drugdu
- 89
- October 6, 2024
The China Securities Regulatory Commission encourages cross-border mergers and acquisitions of unprofitable assets, and a new path for Biotech to land in the capital market?

Wu Qing, chairman of the China Securities Regulatory Commission, said at a press conference of the State Council that in order to further stimulate the vitality of the M&A and restructuring market, the CSRC has studied and formulated the “Opinions on Deepening the Reform of the M&A and Restructuring Market of Listed Companies” (“M&A Six”, hereinafter referred to as the “Opinions”), including supporting the transformation and upgrading of listed companies in the direction of new quality productivity, encouraging industrial integration, improving regulatory tolerance, and improving the transaction efficiency of the restructuring market. Among them, it is clear that it will vigorously support listed companies to carry out cross-industry mergers and acquisitions and acquisitions of unprofitable assets based on transformation and upgrading. This means that unprofitable biotech companies may usher in a new path to land in the capital market. At the meeting, Wu Qing said that mergers and acquisitions are ...
- Source: drugdu
- 78
- October 5, 2024

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.